Welcome to OCIN2022| President Liu Jianmin: Look Forward to the Future with Colleagues in the Field of Cerebrovascular Diseases

From December 15 to 18, 2022, OCIN will be held in Shanghai. We will gather together with colleagues to further realize the full dialogue between the international perspective and China's experience.

 

We will gather together with colleagues around the world to share the feast, spread the fruitful results of the diagnosis and treatment of cerebrovascular diseases in China to the world, and further realize the full dialogue between the international perspective and China's experience.

The annual OCIN allows China to touch the frontiers of the world, and at the same time, let the world feel the pulse of China.

From December15 to 18, 2022, OCIN will open again. Professor Liu Jianmin, president of the conference, sincerely invites colleagues from all walks of life to join us:

 

Dear distinguished colleagues and friends:

I am Dr. Liu Jianmin from Shanghai Changhai Hospital.

From December 15 to 18, 2022, OCIN will be held in Shanghai. As the president of the conference, I would like to sincerely welcome the arrival of all the colleagues in the field of cerebrovascular disease on behalf of all the organizing committee.

With the full support of cerebrovascular doctors at home and abroad, OCIN has developed into an important platform for international academic exchanges in the field of cerebrovascular disease after more than 20 years of refining.

This year, OCIN has carefully set and replanned the form and academic schedule of the conference to meet the needs of clinical first-line diagnosis and treatment, combined with the progress of cerebrovascular disease diagnosis and treatment in the world and the trend of neurointervention technology, so that every participant can find the knowledge and content they want to know.

Finally, I sincerely invite all colleagues again to gather together in Shanghai from December 15 to 18, to look forward to the future, work together to make breakthroughs and innovations, and benefit more patients!